Challenges

International partnerships in the chemico-biology of medicinal resources between China, Pakistan, and Thailand face significant yet surmountable challenges, such as differences in regulatory frameworks, logistical barriers in cross-border research, and the need for sustained funding threaten long-term progress. Moreover, aligning diverse academic priorities while navigating geopolitical complexities demands strategic coordination.

Guangxi Normal University is doubling down on institutional collaboration to secure a sustainable future. The Sino-Pakistan Joint International Laboratory and the newly established China-ASEAN Technology Innovation Center for Natural Medicine are pivotal in streamlining research efforts. Academic exchanges, joint degree programs, and high-profile forums like the Lijiang International Forum on Pharmaceutical Sciences aim to bridge gaps and amplify impact. With strong governmental backing, particularly for Belt and Road scientific initiatives, these partnerships are poised to transform challenges into breakthroughs, advancing global health innovation for SDGs 3, 4, 9 and 17.

Toward a Solution

The initiative spearheaded by Guangxi Normal University in partnership with institutions from Pakistan and Thailand aims to address transnational challenges in medicinal resources research while advancing several Sustainable Development Goals (SDGs), including SDG 3 (Good Health and Well-being), SDG 4 (Quality Education), SDG 9 (Industry, Innovation, and Infrastructure), and SDG 17 (Partnerships for the Goals). By fostering cross-border collaboration, the initiative seeks to bridge gaps in regulatory frameworks, resource sharing, and sustainable funding, ultimately enhancing the global health innovation and knowledge exchange.

To achieve these objectives, the team led by Prof. Hong Liang from Guangxi Normal University adopted a multi-stakeholder, participatory approach. Key methodologies included the establishment of joint research platforms, such as the Sino-Pakistan Joint International Laboratory and the China-ASEAN Technology Innovation Center for Natural Medicine, which served as hubs for collaborative research and capacity building. These platforms integrated shared governance models, with rotating leadership and bilateral secretariats to ensure equitable participation. Academic exchanges, joint training programs, and dual-degree certifications further strengthened institutional ties, while high-profile forums like the Lijiang International Pharmacy Forum amplified visibility and fostered dialogue among researchers, policymakers, and industry leaders.

The process was highly participatory, with concerted actions including regular joint research projects, cross-border supervision of graduate students, and co-authored publications. For example, the recruitment of Dr. Yan Wang from Pakistan’s team and her subsequent contributions to Sino-Pakistan research exemplify the initiative’s commitment to talent mobility. Additionally, the initiative prioritized policy harmonization, working with governmental bodies to align standards and secure funding for long-term projects, such as the Belt and Road Joint Laboratory cultivation program.

A cornerstone of the initiative’s success was its emphasis on systemic, South-South knowledge transfer. By leveraging Pakistan’s expertise in natural product chemistry and Thailand’s strengths in traditional medicine, the partnership created a synergistic framework for addressing transnational challenges, such as drug discovery and sustainable resource utilization, that no single country could tackle alone. This transfer was facilitated through joint patents, standardized protocols, and regional workshops, ensuring mutual benefit and equitable growth.

Quantifiable outcomes underscore the initiative’s impact. By 2025, the collaboration had yielded over 30 high-impact joint publications, 2 patented technologies, and the training of 20+ postgraduate students through exchange programs. Two approved projects entitled “Talent Introduction Base for Medicinal Resources Chemical Biology Discipline Innovation” and “China-ASEAN Technology Innovation Center for Natural Medicine” received 2 and 5 million CNY, respectively. The Sino-Pakistan Lab’s research on antiviral compounds contributed directly to SDG 3 targets on combating infectious diseases. These achievements were complemented by policy impacts, including the formalization of two bilateral cooperation agreements and the integration of joint research priorities into national science strategies in China, Pakistan, and Thailand.

The initiative’s innovative edge lay in its dual focus on academic excellence and industrial application. By aligning fundamental research with market needs, such as developing affordable herbal therapeutics for ASEAN and South Asian markets, it enhanced the competitive advantage of partner countries. The establishment of spin-off enterprises and technology transfer offices further ensured that research outcomes translated into tangible economic benefits.

Sustainability was embedded through institutionalization. The 10-year framework agreements with the Pakistan partner, renewable funding mechanisms, and embedded governance structures (e.g., joint secretariats) ensure continuity. Policy spillovers, such as the adoption of quality control standards for herbal medicines, will demonstrate the long-term systemic impact of traditional Chinese medicine. Regional integration efforts, like the ASEAN-centric research consortia, further solidify its legacy.

The model’s replicability is evidenced by its adaptability to diverse contexts. Key conditions for success include strong institutional buy-in, with clear MoUs and shared governance, diversified funding streams, blending government grants and private-sector partnerships, cultural competency frameworks to navigate regional differences, and policy advocacy to align national regulations with collaborative goals.

Lessons learned highlight the importance of early engagement of policymakers to secure regulatory support, investing in “bridge” personnel to mediate cultural and technical gaps, and balancing academic and applied research to attract both scholarly and commercial stakeholders.

In conclusion, this initiative exemplifies how South-South collaboration can transform systematic challenges into opportunities for sustainable development. Its holistic approach, combining research, education, and policy, offers a blueprint for transnational partnerships aiming to accelerate the progress toward the SDGs.